Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc TLRY


Primary Symbol: T.TLRY

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HE...


TSX:TLRY - Post by User

Post by quinlashon Sep 25, 2025 11:33am
63 Views
Post# 36727407

TLRY Zack's Estimate $240 mil

TLRY Zack's Estimate $240 milZacks is estimating Tilray will report $240.05 million.  Fintel @ $245 Million

Is it too much to suggest that everyone Google that to confirm ?

Forums ARE NOT RESEARCH.  Looking things up on your own IS.

Here's reality. 

Tilray is not obligated to report either of those numbers.   Estimates by Fintel + Zacks are just that ESTIMATES / THEIR BEST GUESS.

Should Tilray see extra revenue through the armada of new products they released this year, new revenue from Germany, Portugal, Italy, Australia, etc then they could come in higher. 

Should the new products, international deals etc not be far enough along yet to see notable increases in revenue then the numbers may be closer to the prior report.

The company is expanding, without doubt. Most of this expansion is overseas.  Expansion takes time and the benefits from this take time to show up in the revenue numbers.

IMHO the report will beat revene from the 2025 Q4 Report.

I would strongly suggest everyone be familiar with (at minimum) the last report so that you yourself know, with confidence, how that report looked.

Trust your own research, don't expect someone else to manage that for you.

Best Regards 

Q

- Long on TLRY 























<< Previous
Bullboard Posts
Next >>